Related Experiment Video
Updated: Jan 30, 2026

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
Published on: June 22, 2017
Anti-parasitic effect on Toxoplasma gondii induced by a spider peptide lycosin-I
Yaqin Tang1, Shengjie Hou1, Xianyao Li1
1Department of Parasitology, Xiangya School of Medicine, Central South University, Changsha, Hunan, 410013, PR China.
Abstract:
Toxoplasmosis is a widely distributed parasitic protozoan disease, caused by Toxoplasma gondii (T. gondii). High prevalence of toxoplasmosis and limitations of conventional treatments lead to a search for new therapeutic drugs. Lycosin-I is a linear peptide, derived from the venom of the spider Lycosa singoriensis. The aim of the present study was to determine the anti-parasitic effect of lycosin-Ι against T. gondii. In vitro, the anti-T. gondii activities of lycosin-Ι were evaluated by MTT assay, trypan blue exclusion assay, cell counting assay and plaque assay. Cytokines of IL-6 and IL-8 were measured by quantitative PCR. In addition, the structures of tachyzoites treated with lycosin-Ι were also observed by scanning and transmission electron microscopy. In vivo, mice were challenged with parasites treated by lycosin-I. The results revealed that lycosin-Ι had shown a significant ability to inhibit T. gondii invasion and proliferation. Cytokines of IL-6 and IL-8 were reduced by lycosin-Ι at transcription level in human foreskin fibroblast (HFF) cells infected with T. gondii tachyzoites, but they were increased compared to non-infected cells. For tachyzoites, lycosin-Ι induced their cell membrane alterations with formation of invaginations, some of them appeared to be vacuolated in their cytoplasm. Moreover, lycosin-Ι had prolonged the survival time of mice by controlling T. gondii proliferation. In conclusion, our present study provides the first evidence for anti-T. gondii by using the spider peptide lycosin-Ι. These findings suggest that lycosin-Ι is a potential alternative agent for the treatment of toxoplasmosis.
Insights
Spider peptide lycosin-I shows significant anti-parasitic effects against Toxoplasma gondii (T. gondii). This research indicates lycosin-I
Area of Science:
- Parasitology
- Pharmacology
- Biochemistry
Background:
- Toxoplasmosis, caused by Toxoplasma gondii (T. gondii), is a widespread parasitic disease.
- Current treatments for toxoplasmosis have limitations, necessitating the development of novel therapeutic agents.
- Lycosin-I, a peptide from Lycosa singoriensis spider venom, is a potential candidate for new drug development.
Purpose of the Study:
- To investigate the anti-parasitic activity of lycosin-I against T. gondii.
- To evaluate the effects of lycosin-I on T. gondii invasion, proliferation, and host cell cytokine response.
- To explore the structural changes in T. gondii tachyzoites induced by lycosin-I.
Main Methods:
- In vitro assays (MTT, trypan blue exclusion, cell counting, plaque assay) were used to assess anti-T. gondii activity.
- Quantitative PCR measured IL-6 and IL-8 cytokine levels.
- Scanning and transmission electron microscopy examined tachyzoite structures.
- In vivo studies involved challenging mice with T. gondii treated with lycosin-I.
Main Results:
- Lycosin-I significantly inhibited T. gondii invasion and proliferation in vitro.
- Lycosin-I reduced IL-6 and IL-8 cytokine expression in infected cells.
- Electron microscopy revealed alterations in tachyzoite cell membranes and cytoplasm.
- In vivo, lycosin-I prolonged mouse survival by controlling parasite proliferation.
Conclusions:
- Lycosin-I demonstrates significant anti-T. gondii activity, inhibiting both invasion and proliferation.
- The study provides the first evidence of lycosin-I's efficacy against T. gondii.
- Lycosin-I is a promising potential therapeutic agent for treating toxoplasmosis.
Related Concept Videos
Peptide Bonds
Epiphytes, Parasites, and Carnivores
Symbiosis
Waterproofing and Anti-Bacterial Admixtures in Concrete
Waterproofing admixtures render concrete hydrophobic,...
Radical Anti-Markovnikov Addition to Alkenes: Mechanism
The mechanism starts with chain initiation, which involves two steps. In the first chain initiation step, a weak peroxide bond is homolytically cleaved upon mild heating to form two alkoxy radicals. In the second initiation step, a hydrogen atom is abstracted by the alkoxy...
Oxidation of Alkenes: Anti Dihydroxylation with Peroxy Acids

